European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer Prior Studies where for early stage breast cancer now there is incredible data for dealing with later stage and higher risk breast cancer patients. This is big news it moves when it moves I will keep adding at these levels!
Presently waiting on FDA approval for marketing the prosense device for breast cancer in the US. I think early to mid 2025 will be where a ton of good news will flow in. In the meantime we should await quarterly results and accumulate.